Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Botulinum toxin type A 100unit inj vials
0409030B0AAAEAE
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | 15 |
|
Botulinum toxin type A 50unit inj vials
0409030B0AAADAD
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | 1 |
|
Botulinum toxin type A 125unit inj vials
0409030B0AAAFAF
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
|
Botulinum toxin type A 200unit inj vials
0409030B0AAAGAG
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
|
Botulinum toxin type A 300unit inj vials
0409030B0AAAHAH
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
|
Botulinum toxin type A 500unit inj vials
0409030B0AAAAAA
|
Botulinum toxin type A | Botulinum toxin type A | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.